Pfizer Crashes 9% As Seagen Guidance Update Disappoints
stock careened lower Wednesday after the pharmaceuticals heavyweight issued disappointing 2024 guidance ahead of its acquisition of Seagen, now expected to close Thursday. The company called for $58.5 billion to $61.5 billion in sales. At the midpoint, that would be roughly flat compared with…
#seagen #pfizer #leerinkpartners #davidrisinger #bntx #nvax #moderna #novavax #bothell #allisongatlin